Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Return on Capital Employed (2016 - 2025)

Catalyst Pharmaceuticals (CPRX) has disclosed Return on Capital Employed for 13 consecutive years, with 0.28% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed fell 1.0% year-over-year to 0.28%, compared with a TTM value of 0.28% through Dec 2025, down 1.0%, and an annual FY2025 reading of 0.31%, down 5.0% over the prior year.
  • Return on Capital Employed was 0.28% for Q4 2025 at Catalyst Pharmaceuticals, down from 0.29% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.36% in Q1 2023 and bottomed at 0.15% in Q2 2024.
  • Average Return on Capital Employed over 3 years is 0.26%, with a median of 0.28% recorded in 2024.
  • The sharpest move saw Return on Capital Employed dropped -20bps in 2024, then increased 15bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.24% in 2023, then grew by 19bps to 0.28% in 2024, then dropped by -2bps to 0.28% in 2025.
  • Business Quant data shows Return on Capital Employed for CPRX at 0.28% in Q4 2025, 0.29% in Q3 2025, and 0.29% in Q2 2025.